Delivery Order SPE2DB22D1041-SPE2DB24FUAG1
Award Date
3/13/24
Potential Completion Date
3/14/24
Potential Value
$10K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide pioglitazone hydrochloride 45 mg tablets. The $1,658.91 contract has an ultimate completion date of April 4, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,056.91 firm fixed-price delivery order is for the supply of 4,566,474,890 units of Pioglitazone HCL 15 mg tablets, with a completion date of November 20, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Pioglitazone HCL 30 mg tablets. The contract, valued at $1,186.51, has an ultimate completion date of April 3, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,186.98 firm fixed-price delivery order covers the supply of Pioglitazone HCL 15 mg tablets. The contract has a period of performance through November 14, 2024 and was awarded on November 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,265.39 firm fixed-price contract is for the supply of Pioglitazone HCL 45 mg tablets. The contract has an ultimate completion date of April 19, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,119.36 firm fixed-price delivery order is for the supply of Pioglitazone HCL 15 mg tablets to support military healthcare programs. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,222.01 Firm Fixed Price Delivery Order contract covers the supply of 4,566,832,860 units of the pharmaceutical drug Pioglitazone HCL 30 mg tablets. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,058 units of the prescription medication Pioglitazone HCl 30 mg tablets. The $2,138.59 firm fixed-price Delivery Order was awarded by the Defense Logistics Agency (DLA), a defense agency within the Department of Defense (DoD), with a final completion date of July 3, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999 Indefinite Delivery...
This federal contract award, with ID SPE2DB20D3103|SPE2DB24FN3V4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company. The $6,395.86 contract is for the delivery of 4,564,234,410 units of pioglitazone HCL 45 mg tablets. The contract has a firm fixed-price pricing type and runs through April 11, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the System for Award...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,136.43 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Pioglitazone HCL 45 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...